Aquaculture Vaccines Market Size, Share & Trends Analysis Report By Vaccine Type (Inactivated Vaccine, Attenuated Live Vaccine, DNA Vaccine, Others), By Route of Administration, By Species, By Application, By Region, And By Segment Forecasts, 2025-2034

Report Id: 1388 Pages: 180 Last Updated: 19 March 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Aquaculture Vaccines Market Segmentation:

By Vaccine Type-

  • Inactivated Vaccine
  • Attenuated Live Vaccine
  • DNA Vaccine
  • Others 

aquaculture vaccine

By Application-

  • Bacterial Infection
  • Viral Infections,
  • Combined Bacterial and Viral Infections
  • Others

By Route of Administration-

  • Immersion Vaccines
  • Injection Vaccines
  • Oral Vaccines

By Species-

  • Salmon
  • Seabass and Seabream
  • Tilapia
  • Trout
  • Turbot
  • Carp

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Aquaculture Vaccines Market Snapshot

Chapter 4. Global Aquaculture Vaccines Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Global Aquaculture Vaccines Market Penetration & Growth Prospect Mapping (US$ Mn),
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Aquaculture Vaccines Market Industry Trends

Chapter 5. Aquaculture Vaccines Market Segmentation 1: By Vaccine Type, Estimates & Trend Analysis
5.1. Market Share by Vaccine Type, 2023 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Vaccine Type:

5.2.1. Inactivated Vaccine
5.2.2. Attenuated Live Vaccine
5.2.3. Others

Chapter 6. Aquaculture Vaccines Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2023 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:

6.2.1. Bacterial Infection
6.2.2. Viral Infections,
6.2.3. Others - Combined Bacterial and Viral Infections, parasitic

Chapter 7. Aquaculture Vaccines Market Segmentation 3: By Route of Administration, Estimates & Trend Analysis
7.1. Market Share by Route of Administration, 2023 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Route of Administration:
7.2.1. Immersion Vaccines
7.2.2. Injection Vaccines
7.2.3. Oral Vaccines

Chapter 8. Aquaculture Vaccines Market Segmentation 4: By Species, Estimates & Trend Analysis
8.1. Market Share by Species, 2023 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Species:

8.2.1. Cold Water
8.2.1.1. Salmon
8.2.1.2. Trout
8.2.1.3. Turbot
8.2.1.4. Others
8.2.2. Hot Water
8.2.2.1. Tilapia
8.2.2.2. Seabass and Seabream
8.2.2.3. Others

Chapter 9. Aquaculture Vaccines Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Aquaculture Vaccines Market, Regional Snapshot 2023 & 2034
9.2. North America
9.2.1. North America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Vaccine Type, 2024-2034
9.2.3. North America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2034
9.2.4. North America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2034
9.2.5. North America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Species, 2024-2034
9.3. Europe
9.3.1. Europe Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2034
9.3.1.1. Norway
9.3.1.2. Greece
9.3.1.3. Spain
9.3.1.4. Russia
9.3.1.5. UK
9.3.1.6. Rest of Europe
9.3.2. Europe Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Vaccine Type, 2024-2034
9.3.3. Europe Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2034
9.3.4. Europe Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2034
9.3.5. Europe Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Species, 2024-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2034
9.4.1.1. China
9.4.1.2. Indonesia
9.4.1.3. Vietnam
9.4.1.4. india
9.4.1.5. Bangladesh
9.4.1.6. Phillipines
9.4.1.7. Rest of Asia Pacific
9.4.2. Asia Pacific Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Vaccine Type, 2024-2034
9.4.3. Asia Pacific Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2034
9.4.4. Asia Pacific Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts By Route of Administration, 2024-2034
9.4.5. Asia Pacific Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Species, 2024-2034
9.5. Latin America
9.5.1. Latin America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2034
9.5.1.1. Chile
9.5.1.2. Brazil
9.5.1.3. Mexico
9.5.1.4. Ecuador
9.5.1.5. Rest of Latin America
9.5.2. Latin America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Vaccine Type, 2024-2034
9.5.3. Latin America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2034
9.5.4. Latin America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2034
9.5.5. Latin America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Species, 2024-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2034
9.6.1.1. Egypt
9.6.1.2. Turkey
9.6.1.3. Iran
9.6.1.4. GCC countries
9.6.1.5. Rest of Middle East and Africa
9.6.2. Middle East & Africa Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Vaccine Type, 2024-2034
9.6.3. Middle East & Africa Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2034
9.6.4. Middle East & Africa Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2034
9.6.5. Middle East & Africa Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Species, 2024-2034

Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles

10.2.1. Pharmaq AS (Zoetis, LLC)
10.2.1.1. Business Overview
10.2.1.2. Key Product/Service
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Merck Animal Health (Merck & Co., Inc.)
10.2.3. KoVax Ltd. (Part of Phibro Animal Health)
10.2.4. Hipra
10.2.5. Tecnovax SA
10.2.6. Veterquimica S.A.
10.2.7. Nisseiken Co. Ltd.
10.2.8. Virbac S.A.
10.2.9. Elanco
10.2.10. Kyoritsuseiyaku Corporation
10.2.11. Vaxxinova International BV
10.2.12. KBNP
10.2.13. Kemin Industries, Inc.
10.2.14. Kyoto Biken Laboratories, Inc.
10.2.15. CAVAC
10.2.16. Other Prominent Players

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
3838
Security Code field cannot be blank!

Frequently Asked Questions

Aquaculture Vaccines Market Size is valued at USD 477.1 Million in 2023 and is predicted to reach 1003.7 Million by the year 2034

Aquaculture Vaccines Market expected to grow at 7.5% CAGR during the forecast period for 2024-2034

Pharmaq AS (Zoetis, LLC) (Norway), Merck Animal Health (Merck & Co., Inc.) (USA), KoVax Ltd. (Part of Phibro Animal Health) (Israel), Hipra (Spain), T

Aquaculture Vaccines market is segmented on the vaccine type, application, route of administration and species.

The North American region is leading the Aquaculture Vaccines market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying